The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Implantable Neurostimulation Devices-Global Market Insights and Sales Trends 2025

Implantable Neurostimulation Devices-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1816890

No of Pages : 91

Ask Your Query

Synopsis
Neurostimulation is a therapeutic activation of part of the nervous system using microelectrodes. The electrodes are used to interface with excitable tissue in order to either restore sensation, such as a cochlear implant for hearing, or control anorgan, such as a heart pacemaker.

Neurostimulation technology improves the life quality of those who are severely paralyzed or suffering from profound losses to various sense organs. It serves as the key part of neural prosthetics for hearing aids, artificial vision, artificial limbs, and brain-machine interfaces. In the case of neural stimulation, mostly an electrical stimulation is utilized and charge-balanced biphasic constant current waveforms of capacitive coupled charge injection approaches are adopted. Alternatively, the transcranial magnetic stimulation has been proposed as a non-invasive method in which a magnetic field causes neurostimulation.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

The global Implantable Neurostimulation Devices market size is expected to reach US$ 14080 million by 2029, growing at a CAGR of 11.2% from 2023 to 2029. The market is mainly driven by the significant applications of Implantable Neurostimulation Devices in various end use industries. The expanding demands from the Pain Management, Parkinson's Disease, Urinary and Fecal Incontinence and Epilepsy, are propelling Implantable Neurostimulation Devices market. Spinal Cord Stimulation (SCS), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Gastric Electric Stimulation (GES) segment is estimated at % CAGR for the next seven-year period.

Global Implantable Neurostimulation Devices key players include Medtronic, Boston Scientific, St. Jude Medical (Abbott), etc. Global top three manufacturers hold a share over 75%.

North America is the largest market, with a share over 80%, followed by Europe, and Asia (Ex.China), both have a share about 10 percent.

In terms of product, Spinal Cord Stimulation (SCS) is the largest segment, with a share over 55%. And in terms of application, the largest application is Pain Management, followed by Parkinson’s Disease, Epilepsy, Urinary and Fecal Incontinence, etc.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Implantable Neurostimulation Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Implantable Neurostimulation Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Implantable Neurostimulation Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Implantable Neurostimulation Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Implantable Neurostimulation Devices covered in this report include Medtronic, Boston Scientific, St. Jude Medical (Abbott), LivaNova, Nevro, NeuroPace, Beijing Pins and Synapse Biomedical, etc.
The global Implantable Neurostimulation Devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.

Market Segmentation
Company Profiles:

  • Medtronic
  • Boston Scientific
  • St. Jude Medical (Abbott)
  • LivaNova
  • Nevro
  • NeuroPace
  • Beijing Pins
  • Synapse Biomedical

Global Implantable Neurostimulation Devices market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Implantable Neurostimulation Devices market, Segment by Type:

  • Spinal Cord Stimulation (SCS)
  • Gastric Electric Stimulation (GES)
  • Deep Brain Stimulation (DBS)
  • Sacral Nerve Stimulation (SNS)
  • Vagus Nerve Stimulation (VNS)
  • Others

Global Implantable Neurostimulation Devices market, by Application

  • Pain Management
  • Parkinson's Disease
  • Urinary and Fecal Incontinence
  • Epilepsy
  • Gastroparesis
  • Others

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Implantable Neurostimulation Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Implantable Neurostimulation Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Index

1 Implantable Neurostimulation Devices Market Overview
1.1 Implantable Neurostimulation Devices Product Overview
1.2 Implantable Neurostimulation Devices Market Segment by Type
1.2.1 Spinal Cord Stimulation (SCS)
1.2.2 Gastric Electric Stimulation (GES)
1.2.3 Deep Brain Stimulation (DBS)
1.2.4 Sacral Nerve Stimulation (SNS)
1.2.5 Vagus Nerve Stimulation (VNS)
1.2.6 Others
1.3 Global Implantable Neurostimulation Devices Market Size by Type
1.3.1 Global Implantable Neurostimulation Devices Market Size Overview by Type (2018-2029)
1.3.2 Global Implantable Neurostimulation Devices Historic Market Size Review by Type (2018-2023)
1.3.3 Global Implantable Neurostimulation Devices Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Implantable Neurostimulation Devices Sales Breakdown by Type (2018-2023)
1.4.2 Europe Implantable Neurostimulation Devices Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Implantable Neurostimulation Devices Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Implantable Neurostimulation Devices Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Implantable Neurostimulation Devices Sales Breakdown by Type (2018-2023)
2 Global Implantable Neurostimulation Devices Market Competition by Company
2.1 Global Top Players by Implantable Neurostimulation Devices Sales (2018-2023)
2.2 Global Top Players by Implantable Neurostimulation Devices Revenue (2018-2023)
2.3 Global Top Players by Implantable Neurostimulation Devices Price (2018-2023)
2.4 Global Top Manufacturers Implantable Neurostimulation Devices Manufacturing Base Distribution, Sales Area, Product Type
2.5 Implantable Neurostimulation Devices Market Competitive Situation and Trends
2.5.1 Implantable Neurostimulation Devices Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Implantable Neurostimulation Devices Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Implantable Neurostimulation Devices as of 2022)
2.7 Date of Key Manufacturers Enter into Implantable Neurostimulation Devices Market
2.8 Key Manufacturers Implantable Neurostimulation Devices Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Implantable Neurostimulation Devices Status and Outlook by Region
3.1 Global Implantable Neurostimulation Devices Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Implantable Neurostimulation Devices Historic Market Size by Region
3.2.1 Global Implantable Neurostimulation Devices Sales in Volume by Region (2018-2023)
3.2.2 Global Implantable Neurostimulation Devices Sales in Value by Region (2018-2023)
3.2.3 Global Implantable Neurostimulation Devices Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Implantable Neurostimulation Devices Forecasted Market Size by Region
3.3.1 Global Implantable Neurostimulation Devices Sales in Volume by Region (2024-2029)
3.3.2 Global Implantable Neurostimulation Devices Sales in Value by Region (2024-2029)
3.3.3 Global Implantable Neurostimulation Devices Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Implantable Neurostimulation Devices by Application
4.1 Implantable Neurostimulation Devices Market Segment by Application
4.1.1 Pain Management
4.1.2 Parkinson's Disease
4.1.3 Urinary and Fecal Incontinence
4.1.4 Epilepsy
4.1.5 Gastroparesis
4.1.6 Others
4.2 Global Implantable Neurostimulation Devices Market Size by Application
4.2.1 Global Implantable Neurostimulation Devices Market Size Overview by Application (2018-2029)
4.2.2 Global Implantable Neurostimulation Devices Historic Market Size Review by Application (2018-2023)
4.2.3 Global Implantable Neurostimulation Devices Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Implantable Neurostimulation Devices Sales Breakdown by Application (2018-2023)
4.3.2 Europe Implantable Neurostimulation Devices Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Implantable Neurostimulation Devices Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Implantable Neurostimulation Devices Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Implantable Neurostimulation Devices Sales Breakdown by Application (2018-2023)
5 North America Implantable Neurostimulation Devices by Country
5.1 North America Implantable Neurostimulation Devices Historic Market Size by Country
5.1.1 North America Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Implantable Neurostimulation Devices Sales in Volume by Country (2018-2023)
5.1.3 North America Implantable Neurostimulation Devices Sales in Value by Country (2018-2023)
5.2 North America Implantable Neurostimulation Devices Forecasted Market Size by Country
5.2.1 North America Implantable Neurostimulation Devices Sales in Volume by Country (2024-2029)
5.2.2 North America Implantable Neurostimulation Devices Sales in Value by Country (2024-2029)
6 Europe Implantable Neurostimulation Devices by Country
6.1 Europe Implantable Neurostimulation Devices Historic Market Size by Country
6.1.1 Europe Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Implantable Neurostimulation Devices Sales in Volume by Country (2018-2023)
6.1.3 Europe Implantable Neurostimulation Devices Sales in Value by Country (2018-2023)
6.2 Europe Implantable Neurostimulation Devices Forecasted Market Size by Country
6.2.1 Europe Implantable Neurostimulation Devices Sales in Volume by Country (2024-2029)
6.2.2 Europe Implantable Neurostimulation Devices Sales in Value by Country (2024-2029)
7 Asia-Pacific Implantable Neurostimulation Devices by Region
7.1 Asia-Pacific Implantable Neurostimulation Devices Historic Market Size by Region
7.1.1 Asia-Pacific Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Implantable Neurostimulation Devices Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Implantable Neurostimulation Devices Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Implantable Neurostimulation Devices Forecasted Market Size by Region
7.2.1 Asia-Pacific Implantable Neurostimulation Devices Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Implantable Neurostimulation Devices Sales in Value by Region (2024-2029)
8 Latin America Implantable Neurostimulation Devices by Country
8.1 Latin America Implantable Neurostimulation Devices Historic Market Size by Country
8.1.1 Latin America Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Implantable Neurostimulation Devices Sales in Volume by Country (2018-2023)
8.1.3 Latin America Implantable Neurostimulation Devices Sales in Value by Country (2018-2023)
8.2 Latin America Implantable Neurostimulation Devices Forecasted Market Size by Country
8.2.1 Latin America Implantable Neurostimulation Devices Sales in Volume by Country (2024-2029)
8.2.2 Latin America Implantable Neurostimulation Devices Sales in Value by Country (2024-2029)
9 Middle East and Africa Implantable Neurostimulation Devices by Country
9.1 Middle East and Africa Implantable Neurostimulation Devices Historic Market Size by Country
9.1.1 Middle East and Africa Implantable Neurostimulation Devices Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Implantable Neurostimulation Devices Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Implantable Neurostimulation Devices Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Implantable Neurostimulation Devices Forecasted Market Size by Country
9.2.1 Middle East and Africa Implantable Neurostimulation Devices Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Implantable Neurostimulation Devices Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Medtronic
10.1.1 Medtronic Company Information
10.1.2 Medtronic Introduction and Business Overview
10.1.3 Medtronic Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Medtronic Implantable Neurostimulation Devices Products Offered
10.1.5 Medtronic Recent Development
10.2 Boston Scientific
10.2.1 Boston Scientific Company Information
10.2.2 Boston Scientific Introduction and Business Overview
10.2.3 Boston Scientific Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Boston Scientific Implantable Neurostimulation Devices Products Offered
10.2.5 Boston Scientific Recent Development
10.3 St. Jude Medical (Abbott)
10.3.1 St. Jude Medical (Abbott) Company Information
10.3.2 St. Jude Medical (Abbott) Introduction and Business Overview
10.3.3 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.3.4 St. Jude Medical (Abbott) Implantable Neurostimulation Devices Products Offered
10.3.5 St. Jude Medical (Abbott) Recent Development
10.4 LivaNova
10.4.1 LivaNova Company Information
10.4.2 LivaNova Introduction and Business Overview
10.4.3 LivaNova Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.4.4 LivaNova Implantable Neurostimulation Devices Products Offered
10.4.5 LivaNova Recent Development
10.5 Nevro
10.5.1 Nevro Company Information
10.5.2 Nevro Introduction and Business Overview
10.5.3 Nevro Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Nevro Implantable Neurostimulation Devices Products Offered
10.5.5 Nevro Recent Development
10.6 NeuroPace
10.6.1 NeuroPace Company Information
10.6.2 NeuroPace Introduction and Business Overview
10.6.3 NeuroPace Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.6.4 NeuroPace Implantable Neurostimulation Devices Products Offered
10.6.5 NeuroPace Recent Development
10.7 Beijing Pins
10.7.1 Beijing Pins Company Information
10.7.2 Beijing Pins Introduction and Business Overview
10.7.3 Beijing Pins Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Beijing Pins Implantable Neurostimulation Devices Products Offered
10.7.5 Beijing Pins Recent Development
10.8 Synapse Biomedical
10.8.1 Synapse Biomedical Company Information
10.8.2 Synapse Biomedical Introduction and Business Overview
10.8.3 Synapse Biomedical Implantable Neurostimulation Devices Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Synapse Biomedical Implantable Neurostimulation Devices Products Offered
10.8.5 Synapse Biomedical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Implantable Neurostimulation Devices Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Implantable Neurostimulation Devices Industrial Chain Analysis
11.4 Implantable Neurostimulation Devices Market Dynamics
11.4.1 Implantable Neurostimulation Devices Industry Trends
11.4.2 Implantable Neurostimulation Devices Market Drivers
11.4.3 Implantable Neurostimulation Devices Market Challenges
11.4.4 Implantable Neurostimulation Devices Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Implantable Neurostimulation Devices Distributors
12.3 Implantable Neurostimulation Devices Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock